医院治疗感染性疾病、感染负担与肺癌风险:观察性及孟德尔随机化研究
基于UK Biobank中900余种感染性疾病数据,采用时变Cox模型分析感染与肺癌风险关联,并辅以孟德尔随机化验证因果性。结果显示医院治疗感染性疾病与肺癌风险升高相关(aHR 1.79,95%CI 1.74-1.83),下呼吸道感染影响最强(aHR 3.22),感染负担与肺癌风险呈剂量反应关系,遗传分析支持因果关联。
要点
- 医院治疗感染性疾病与肺癌风险升高独立相关,aHR为1.79。
- 下呼吸道感染对肺癌风险影响最强,aHR达3.22。
- 感染负担与肺癌风险呈剂量反应关系,Ptrend<.001。
核心结论
- 观察性与遗传分析均提示感染性疾病可增加肺癌风险。
- 下呼吸道感染与肺外感染的双重视角可指导肺癌预防策略。
研究设计与样本
- 基于UK Biobank中900余种感染性疾病数据,采用时变Cox比例风险模型评估短期与长期效应。
- 采用生命表法估算肺癌导致的寿命损失年,并以两样本孟德尔随机化验证因果关联。
- 分析中重复排除合并多病原感染或索引感染住院后10年内出现结局的患者。
主要发现
- 医院治疗感染性疾病与肺癌风险升高相关(aHR 1.79,95%CI 1.74-1.83)。
- 不同病原类型的肺癌aHR范围为1.39至2.82。
- 下呼吸道感染对肺癌影响的aHR为3.22(95%CI 2.64-3.92),肺外感染aHR为1.29(95%CI 1.16-1.44)。
- 在不同FEV1占预计值百分比分层中,感染负担与肺癌风险呈剂量反应关联(Ptrend<.001)。
- 多种感染导致50岁时肺癌相关寿命损失显著,孟德尔随机化分析 reaffirmed 因果关联。
关键数值与推荐
- 感染负担定义为随时间累积的感染发作次数与同时发生的感染之和。
- 孟德尔随机化所用全基因组关联研究数据主要来自欧洲 ancestry。
临床怎么用
- 对医院治疗感染性疾病患者,尤其下呼吸道感染者,应加强肺癌风险监测。
- 感染负担可作为肺癌风险评估的参考维度,结合FEV1占预计值百分比分层管理。
局限性
- 孟德尔随机化所用GWAS数据主要来自欧洲 ancestry,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although infections play a role in the development of lung cancer, the longitudinal association between infection and the risk of lung cancer is disputed, and data relating to pathogen types and infection sites are sparse. RESEARCH QUESTION: How do infections affect subsequent lung cancer risk, and is the impact limited to specific microbes rather than infection burden? STUDY DESIGN AND METHODS: Data on > 900 infectious diseases were gathered from the UK Biobank study. Short- and long-term effects of infections were assessed by using time-varying Cox proportional hazards models. The analysis was repeated, excluding patients with concurrent multi-pathogen infections or outcomes within the 10 years following the initial hospitalization for the index infection. A life table approach was used to estimate years of life lost from lung cancer. Infection burden was defined as the sum of the number of infection episodes over time and co-occurring infections. The genome-wide association studies used in two-sample Mendelian randomization were obtained from mostly European ancestry. RESULTS: Hospital-treated infectious disease was associated with a greater risk of lung cancer (adjusted hazard ratio [aHR], 1.79; 95% CI, 1.74-1.83). aHRs for lung cancer ranged from 1.39 to 2.82 across pathogen types. The impact of lower respiratory tract infections (LRTIs) on lung cancer was the strongest, with an aHR of 3.22 (95% CI, 2.64-3.92); the aHR for extra-LRTIs was 1.29 (95% CI, 1.16-1.44). A dose-response association was observed between infection burden and lung cancer risk across different FEV1 percent predicted (Ptrend < .001). Multiple infections led to significant life lost from lung cancer at the age of 50 years. Mendelian randomization analysis reaffirmed the causal association. INTERPRETATION: Both observational and genetic analyses suggest that infectious diseases could increase the risk of lung cancer. The dual perspective on the LRTIs and extra-LRTIs impacts may inform lung cancer prevention strategies.
引用
- Zheng J, Huang J, Yang Q, et al. Hospital-Treated Infectious Diseases, Infection Burden, and Risk of Lung Cancer: An Observational and Mendelian Randomization Study. Chest. 2024. PMID: 39084518. doi:10.1016/j.chest.2024.06.3811
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。